Sabra Healthcare REIT, Inc. (SBRA) Releases FY17 Earnings Guidance
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) issued an update on its FY17 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.29-2.33 for the period, compared to the Thomson Reuters consensus estimate of $2.34. Sabra Healthcare REIT also updated its FY18 guidance to $2.41-2.47 EPS.
Sabra Healthcare REIT, Inc. (SBRA) traded down 1.15% during trading on Thursday, hitting $22.34. The company’s stock had a trading volume of 1,482,744 shares. Sabra Healthcare REIT, Inc. has a 12 month low of $19.30 and a 12 month high of $29.10. The firm has a 50 day moving average of $22.43 and a 200 day moving average of $24.81. The firm has a market cap of $1.46 billion, a P/E ratio of 18.80 and a beta of 0.89.
The firm also recently announced a quarterly dividend, which was paid on Friday, August 18th. Stockholders of record on Wednesday, August 16th were paid a dividend of $0.3599 per share. The ex-dividend date was Monday, August 14th. This represents a $1.44 annualized dividend and a dividend yield of 6.44%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 122.03%.
Several equities research analysts recently weighed in on the company. BidaskClub upgraded Sabra Healthcare REIT from a sell rating to a hold rating in a research report on Tuesday, June 20th. Mizuho restated a neutral rating on shares of Sabra Healthcare REIT in a research report on Wednesday, June 28th. Zacks Investment Research lowered Sabra Healthcare REIT from a hold rating to a sell rating in a research report on Thursday, June 8th. Stifel Nicolaus restated a hold rating and set a $26.00 price target on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. Finally, Jefferies Group LLC restated a hold rating and set a $28.00 price target on shares of Sabra Healthcare REIT in a research report on Friday, May 12th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $25.29.
WARNING: This story was published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2017/09/07/sabra-healthcare-reit-inc-sbra-releases-fy17-earnings-guidance.html.
Sabra Healthcare REIT Company Profile
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.